Assisted Reproductive Technology Market by Technology (In Vitro Fertilization, Artificial Insemination), Type (Instruments (Incubators), Media (Cryopreservation), Supplements, Consumables), Patient Type (Male, Female), End User - Global Forecast to 2030

The assisted reproductive technology market is projected to reach USD 6.02 Billion by 2030 from USD 4.29 Billion in 2025 at a CAGR of 7.0% during the forecast period.

Increasing rates of infertility due to delayed conception, altered lifestyles, and growing awareness of fertility treatment are driving the assisted reproductive technology (ART) market. Further impetus to market growth is coming from improvements in medical technology, improved treatment success rates with in-vitro fertilization (IVF), and favorable government policies. But some of these limitations are the cost of treatment, ethical and legal issues, and health risks associated with ART procedures. Inadequacy of fertility treatment in developing nations and physical and psychological stress of ART also limit market growth. Research and development are, in spite of these limitations, enhancing the price and effectiveness of ART treatments.

“The IVF segment is accounted for the largest share of global assisted reproductive technology market.”

IVF has become the ART procedure of choice over other treatments due to innovations like time-lapse imaging, embryo freezing, and preimplantation genetic testing (PGT), which have greatly enhanced IVF success. Global demand for IVF has also been driven by delayed pregnancy, rising infertility, and greater awareness of fertility treatment. IVF domination of the market is also driven by greater medical tourism practice, government subsidization of ART procedures, and greater numbers of fertility clinics.

Due to its high success rates, commonality of use, and ongoing technological advancements, the IVF category maintains the largest market share in the assisted reproductive technology (ART) market.

The best treatment for infertility, in vitro fertilization (IVF), can treat many different kinds of infertility problems, including unexplained infertility, male factor infertility, and older mother age.

“Fertility clinics has the largest market share in assisted reproductive technology market.”

Fertility clinics enjoy the largest market share among the assisted reproductive technology market in care facilities owing to the growing demand for specialist reproductive treatments, high-technology healthcare facilities, and the increased number of infertile patients worldwide. Since ART therapies provided are heterogeneous in nature, encompassing intrauterine insemination, in-vitro fertilization, freezing eggs and sperm, and preimplantation genetic diagnosis, fertility clinics remain the preferred option for those who require fertility therapies. Expansion of private fertility clinics, government initiatives, and growing awareness regarding reproductive therapies have also driven the growth of this segment. Fertility clinics' dominance in the ART business is also complemented by the growing trend of medical tourism for affordable ART therapy in Thailand, India, and Spain.

“Asia Pacific holds the largest market share in the assisted reproductive technology market.”

Asia-Pacific holds the maximum market share in the ART market due to its large population, large infertility rates, and strong awareness of fertility treatment. There is growing demand for ART treatment in the region at a rapid rate due to factors such as delayed parenthood, changing lifestyles, and high levels of stress that exacerbate fertility. Government-sponsored programs for ART funding, the proliferation of fertility clinics, and advances in reproductive technology have all contributed to the growth in the market. Key drivers are countries such as China, India, and Japan, which offer low-cost fertility treatments that are in great demand among medical tourists. Asia-Pacific's market dominance is also supported by increasing acceptance of ART as well as the increase in the affordability of healthcare and infrastructure.

A breakdown of the primary participants (supply-side) for the assisted reproductive technology market referred to for this report is provided below:

• By Company Type: Tier 1–40%, Tier 2–30%, and Tier 3–30%
• By Designation: C-level–55%, Director Level–27%, and Others–18%
• By Region: North America–35%, Europe–32%, Asia Pacific–25%, Latin America- 5%, and Middle East and Africa– 1% and GCC Countries– 2%

Prominent players in this market include CooperSurgical Inc. (US), FUJIFILM Irvine Scientific (Japan), Vitrolife (Sweden), Hamilton Thorne (US), Cook Medical Inc. (US), Esco Micro Pte. Ltd. (Singapore), Genea BIOMEDX (Australia), Thermo Fisher Scientific Inc. (US), LENUS Pharma GesmbH (Austria), Zita West (UK), Kitazato Corporation (Japan), Exeltis USA, Inc. (US), Vitabiotics Ltd (UK), FertiPro NV (Belgium), and AdvaCare Pharma (US), among others.

Research Coverage:

The market study covers the assisted reproductive technology market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by type, technology, patient type, care setting and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:

• Analysis of Market Dynamics: Drivers (Increasing median age of pregnancy, Rising infertility rate, Booming fertility industry, Evolving technological landscape, Favorable government initiatives) restraints (High cost of IVF procedures, Social and ethical concerns in developing countries, Elevated risk of complications) opportunities (Growth opportunities in emerging economies, Availability of diverse range of fertility treatment options), and challenges (Reduced efficacy of infertility treatments among patients of advanced age)
• Services/Innovations: Detailed insights on upcoming technologies, research & development activities, and new product launches in the assisted reproductive technology market.
• Market Development: Comprehensive information on the lucrative emerging markets, components, demographics, care settings, and region.
• Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the assisted reproductive technology market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the assisted reproductive technology market like CooperSurgical Inc. (US), FUJIFILM Irvine Scientific (Japan), Vitrolife (Sweden), Hamilton Thorne (US), Cook Medical Inc. (US), Esco Micro Pte. Ltd. (Singapore), Genea BIOMEDX (Australia), and Thermo Fisher Scientific Inc. (US).

Show more